𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous System

✍ Scribed by Francisco C. Pérez-Martínez; Javier Guerra; Inmaculada Posadas; Valentín Ceña

Publisher
Springer US
Year
2011
Tongue
English
Weight
481 KB
Volume
28
Category
Article
ISSN
0724-8741

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant AAV-mediated gene delivery t
Recombinant AAV-mediated gene delivery to the central nervous system
✍ L. Tenenbaum; A. Chtarto; E. Lehtonen; T. Velu; J. Brotchi; M. Levivier 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB 👁 1 views

Various regions of the brain have been successfully transduced by recombinant adeno-associated virus (rAAV) vectors with no detected toxicity. When using the cytomegalovirus immediate early (CMV) promoter, a gradual decline in the number of transduced cells has been described. In contrast, the use o

Chitosan-based gene delivery vectors tar
Chitosan-based gene delivery vectors targeted to the peripheral nervous system
✍ Hugo Oliveira; Liliana R. Pires; Ramon Fernandez; M. Cristina L. Martins; Sérgio 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 862 KB

## Abstract A non‐toxic, targeted, simple and efficient system that can specifically transfect peripheral sensorial neurons can pave the way towards the development of new therapeutics for the treatment of peripheral neuropathies. In this study chitosan (CH), a biodegradable polymer, was used as th

siRNA delivery by a transferrin-associat
siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing
✍ A. L. C. Cardoso; S. Simões; L. P. de Almeida; J. Pelisek; C. Culmsee; E. Wagner 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 905 KB

## Abstract ## Background RNA interference provides a powerful technology for specific gene silencing. Therapeutic applications of small interfering RNA (siRNA) however require efficient vehicles for stable complexation, protection, and extra‐ and intracellular delivery of these nucleic acids. Her

The in vivo use of chloroquine to promot
The in vivo use of chloroquine to promote non-viral gene delivery to the liver via the portal vein and bile duct
✍ Xiaohong Zhang; Greta J. Sawyer; Xuebin Dong; Ying Qiu; Louise Collins; Professo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

## Abstract ## Background Assistance with exit from endocytic vesicles is a key factor for non‐viral gene delivery, and is a particular challenge __in vivo__. We have evaluated the __in vivo__ use of chloroquine administered systemically, orally and/or locally for gene delivery to the liver. ## M

Global diffuse distribution in the brain
Global diffuse distribution in the brain and efficient gene delivery to the dorsal root ganglia by intrathecal injection of adeno-associated viral vector serotype 1
✍ Naotaka Iwamoto; Atsushi Watanabe; Motoko Yamamoto; Noriko Miyake; Toshiyuki Kur 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB

## Abstract ## Background The success of gene therapy for inherited neurodegenerative diseases such as metachromatic leukodystrophy (MLD) depends on the development of efficient gene delivery throughout the brain guarded by the blood–brain barrier and achieves distribution of the deficient enzyme